The RSPO2 gene helps guide early body development, especially the growth of limbs, lungs, and parts of the face before birth. This gene plays an important role in how cells respond to growth signals, helping tissues form in the right place at the right time. If the RSPO2 gene does not work properly, severe variants can lead to rare birth conditions with major differences in limb and organ development.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for producing proteins, which do much of the cells’ work. Others mostly guide when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
RSPO2Gene function
What if the gene works
The RSPO2 gene helps boost a key cell messaging pathway that guides growth and tissue formation. It is especially important during early development, including the limbs, lungs, and face.
Risk
What if the gene does not work
More disruptive variants in the RSPO2 gene are linked to major problems in early body development, especially missing or severely shortened limbs and underdeveloped lungs. Milder and more severe variants can influence which features appear and how severe they are.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the RSPO2 gene, so care is guided by a person’s actual symptoms and support needs. The RSPO2 gene is being studied as a possible drug target and biomarker in some cancers and lung conditions, but this has not led to guideline-based treatment choices.
Conditions associated with RSPO2
Gene function
What if the gene works
The RSPO2 gene helps cells pass along growth signals that guide normal tissue building and shape. Its protein works outside cells, where it strengthens a key messaging system used during growth and repair. This helps explain how the RSPO2 gene works in the body during early development and routine tissue maintenance.
One of its main roles is to boost Wnt signaling (a common cell messaging system that guides growth and body patterning). This helps cells receive clear instructions during development and tissue upkeep.
Its protein helps important surface receptors stay available so messages are not switched off too soon. This keeps growth signals steadier and easier for nearby cells to follow.
During early development, the RSPO2 gene supports the organized shaping of tissues and body structures. Cells can better coordinate where to grow and what form to take.
By strengthening these signals, the RSPO2 gene helps some cells settle into the right roles at the right time. This supports normal formation of organs and other body parts.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and form part of normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RSPO2 gene can change the protein’s shape, stability, or release from the cell, which may weaken cell to cell signaling. In descriptions of how RSPO2 gene variants affect protein function, the main pattern is reduced signaling strength rather than a completely new action. Milder variants may leave some activity in place, while more severe variants, including changes that shorten the protein, can greatly reduce or fully stop its effect.
How variants are linked to conditions
Pathogenic variants in the RSPO2 gene are most clearly linked to tetra amelia syndrome type 2, a very rare inherited condition. People with this diagnosis are born with severe limb reduction and may also have lung, airway, or other birth differences. This RSPO2 gene and tetra amelia syndrome link is based on rare families with disease-causing variants, so it describes a confirmed genetic diagnosis rather than a general risk trend.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RSPO2 gene. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of RSPO2 variants
In families affected by an RSPO2-related condition, the RSPO2 inheritance pattern is typically autosomal recessive. This means a child usually inherits one altered copy of the RSPO2 gene from each parent. Parents who each carry one variant often do not have the condition themselves. With each pregnancy, there is a 25% chance the child inherits both altered copies, a 50% chance the child is a carrier like the parents, and a 25% chance the child inherits neither altered copy. Sons and daughters are affected equally.
What does my RSPO2 result mean for my family?
For RSPO2, the best-known inherited condition is passed down in a recessive way. This usually means parents can be healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. For family members, the main question is often whether close relatives could carry the same gene change.
Genetic information
Genetic testing
How you find out about variants
To check for changes in the RSPO2 gene, RSPO2 genetic testing analyzes DNA from a blood sample, saliva, or a cheek swab. A lab usually reads the gene’s code with sequencing (a method that spells out the DNA letters) and compares it with the usual pattern to identify variants, then reports how any variant is currently classified.
When should I consider getting a genetic test?
There is not yet a broadly established reason for RSPO2 testing in most people. Testing may be considered with a genetics specialist when there is a personal or family history of a very rare birth condition affecting limb development or another unexplained finding that suggests this gene could be involved.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, do less for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in a person’s genes can affect the way they respond to medicines. By examining links between genes and medications, it helps explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence both how strong the medicine’s effects are and how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the RSPO2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about symptoms, side effects, or how well a treatment is working are best discussed with your doctor.
History
Researchers identified the RSPO2 gene in the early 2000s while studying a small family of related genes involved in growth and development. It was first described as part of the R-spondin group, which quickly drew attention in developmental biology research. From these first observations, research expanded steadily, linking RSPO2 to early studies of limb, lung, and facial development in animal models and human genetics. Later work also connected changes involving the RSPO2 gene to some tumors, which broadened scientific interest in the gene. Over time, scientists’ understanding of the gene’s role has changed, moving from a newly named discovery to a recognized part of modern genetics research.